Athens Banner Herald/Online Athens, December 6, 2011: Athens researchers believe they’re close to human trials for a device that could use stem cells to control Type 1 diabetes.

Research company Viacyte has labs in both San Diego and Athens, and both have helped develop a potential cure for Type 1 diabetes, said Dr. Allan Robins, Viacyte’s acting CEO and chief technology officer. Robins calls Georgia home, though he splits his time between here and California. Read entire article »